Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × Pemetrexed × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 167 Lung Neoplasms 61 Neoplasms 21 Neoplasm Metastasis 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Mesothelioma, Malignant 12 Colorectal Neoplasms 10 Carcinoma 10 Meningeal Carcinomatosis 9 Mesothelioma 6 Melanoma 6 Brain Neoplasms 6 NSCLC 5 Adenocarcinoma of Lung 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Neoplasms by Site 4 Lung Diseases 4 Carcinoma, Bronchogenic 4 Advanced Solid Tumors 4 Thoracic Neoplasms 3 Small Cell Lung Carcinoma 3 Respiratory Tract Neoplasms 3 Rectal Neoplasms 3 Neoplasms by Histologic Type 3 Endometrial Neoplasms 3 Colonic Neoplasms 3 Bronchial Neoplasms 3

Interventions

pegaspargase 3 tislelizumab 1 sugemalimab 1 relatlimab 1 gemcitabine-oxaliplatin regimen 1 fludarabine phosphate 1 Whole-Body Irradiation 1 Vorinostat 1 Valganciclovir 1 Thiotepa 1 Therapeutics 1 Tacrolimus 1 Sirolimus 1 Radiotherapy 1 Positron-Emission Tomography 1 Polymerase Chain Reaction 1 Peripheral Blood Stem Cell Transplantation 1 Oxaliplatin 1 Nivolumab 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Immune Checkpoint Inhibitors 1 Ice 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Etoposide 1 Cyclosporine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡